These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23093687)

  • 21. Mutations in the ABCC8 (SUR1 subunit of the K(ATP) channel) gene are associated with a variable clinical phenotype.
    Klupa T; Kowalska I; Wyka K; Skupien J; Patch AM; Flanagan SE; Noczynska A; Arciszewska M; Ellard S; Hattersley AT; Sieradzki J; Mlynarski W; Malecki MT
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):358-62. PubMed ID: 19021632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Personalized medicine switching from insulin to sulfonylurea in permanent neonatal diabetes mellitus dictated by a novel activating ABCC8 mutation.
    Mak CM; Lee CY; Lam CW; Siu WK; Hung VC; Chan AY
    Diagn Mol Pathol; 2012 Mar; 21(1):56-9. PubMed ID: 22306677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Permanent neonatal diabetes caused by a novel mutation.
    Jain V; Flanagan SE; Ellard S
    Indian Pediatr; 2012 Jun; 49(6):486-8. PubMed ID: 22796691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Focus on incretin-based therapies: targeting the core defects of type 2 diabetes.
    Jellinger PS
    Postgrad Med; 2011 Jan; 123(1):53-65. PubMed ID: 21293084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Congenital hyperinsulinism caused by mutations in ABCC8 (SUR1) gene.
    Thakur S; Flanagan SE; Ellard S; Verma IC
    Indian Pediatr; 2011 Sep; 48(9):733-4. PubMed ID: 21992908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11.
    Edghill EL; Flanagan SE; Ellard S
    Rev Endocr Metab Disord; 2010 Sep; 11(3):193-8. PubMed ID: 20922570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination pharmacotherapy with incretins: what works best and when?
    Over RK; Ratner RE
    Curr Diab Rep; 2008 Oct; 8(5):361-7. PubMed ID: 18778584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Permanent neonatal diabetes with known genetic background: oral drugs in treatment of childhood diabetes].
    Gach A; Gadzicka A; Młynarski W
    Pediatr Endocrinol Diabetes Metab; 2008; 14(1):45-9. PubMed ID: 18577347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incretin-based therapies: viewpoints on the way to consensus.
    Nauck MA; Vilsbøll T; Gallwitz B; Garber A; Madsbad S
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S223-31. PubMed ID: 19875556
    [No Abstract]   [Full Text] [Related]  

  • 30. A novel ABCC8 mutation illustrates the variability of the diabetes phenotypes associated with a single mutation.
    Klee P; Bellanné-Chantelot C; Depret G; Llano JP; Paget C; Nicolino M
    Diabetes Metab; 2012 Apr; 38(2):179-82. PubMed ID: 22326206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolbutamide controls glucagon release from mouse islets differently than glucose: involvement of K(ATP) channels from both α-cells and δ-cells.
    Cheng-Xue R; Gómez-Ruiz A; Antoine N; Noël LA; Chae HY; Ravier MA; Chimienti F; Schuit FC; Gilon P
    Diabetes; 2013 May; 62(5):1612-22. PubMed ID: 23382449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucagon-like peptide-1 analogues for Type 2 diabetes mellitus: current and emerging agents.
    Gallwitz B
    Drugs; 2011 Sep; 71(13):1675-88. PubMed ID: 21902291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and metabolic features of adult-onset diabetes caused by ABCC8 mutations.
    Riveline JP; Rousseau E; Reznik Y; Fetita S; Philippe J; Dechaume A; Hartemann A; Polak M; Petit C; Charpentier G; Gautier JF; Froguel P; Vaxillaire M
    Diabetes Care; 2012 Feb; 35(2):248-51. PubMed ID: 22210575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Three-year observation of permanent neonatal diabetes].
    Noczyńska A; Zubkiewicz-Kucharska A; Salmonowicz B; Małecki M; Młynarski W
    Pediatr Endocrinol Diabetes Metab; 2010; 16(1):50-4. PubMed ID: 20529607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carriers of an inactivating beta-cell ATP-sensitive K(+) channel mutation have normal glucose tolerance and insulin sensitivity and appropriate insulin secretion.
    Huopio H; Vauhkonen I; Komulainen J; Niskanen L; Otonkoski T; Laakso M
    Diabetes Care; 2002 Jan; 25(1):101-6. PubMed ID: 11772909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. cAMP-activated protein kinase-independent potentiation of insulin secretion by cAMP is impaired in SUR1 null islets.
    Nakazaki M; Crane A; Hu M; Seghers V; Ullrich S; Aguilar-Bryan L; Bryan J
    Diabetes; 2002 Dec; 51(12):3440-9. PubMed ID: 12453898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 17beta-Estradiol modulates apoptosis in pancreatic beta-cells by specific involvement of the sulfonylurea receptor (SUR) isoform SUR1.
    Ackermann S; Hiller S; Osswald H; Lösle M; Grenz A; Hambrock A
    J Biol Chem; 2009 Feb; 284(8):4905-13. PubMed ID: 19095654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New ABCC8 mutations in relapsing neonatal diabetes and clinical features.
    Vaxillaire M; Dechaume A; Busiah K; Cavé H; Pereira S; Scharfmann R; de Nanclares GP; Castano L; Froguel P; Polak M;
    Diabetes; 2007 Jun; 56(6):1737-41. PubMed ID: 17389331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paediatric diabetes--which children can gain insulin independence?
    Srinivasan S; Donaghue KC
    Med J Aust; 2007 May; 186(9):436-7. PubMed ID: 17484702
    [No Abstract]   [Full Text] [Related]  

  • 40. Neonatal diabetes caused by mutations in sulfonylurea receptor 1: interplay between expression and Mg-nucleotide gating defects of ATP-sensitive potassium channels.
    Zhou Q; Garin I; Castaño L; Argente J; Muñoz-Calvo MT; Perez de Nanclares G; Shyng SL
    J Clin Endocrinol Metab; 2010 Dec; 95(12):E473-8. PubMed ID: 20810569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.